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Abstract
The metastatic progression of cancer is a multi-step process initi-
ated by the local invasion of the peritumoral stroma. To identify
the mechanisms underlying colorectal carcinoma (CRC) invasion,
we collected live human primary cancer specimens at the time of
surgery and monitored them ex vivo. This revealed that conven-
tional adenocarcinomas undergo collective invasion while retain-
ing their epithelial glandular architecture with an inward apical
pole delineating a luminal cavity. To identify the underlying mech-
anisms, we used microscopy-based assays on 3D organotypic
cultures of Caco-2 cysts as a model system. We performed two
siRNA screens targeting Rho-GTPases effectors and guanine
nucleotide exchange factors. These screens revealed that ROCK2
inhibition triggers the initial leader/follower polarization of the
CRC cell cohorts and induces collective invasion. We further identi-
fied FARP2 as the Rac1 GEF necessary for CRC collective invasion.
However, FARP2 activation is not sufficient to trigger leader cell
formation and the concomitant inhibition of Myosin-II is required
to induce invasion downstream of ROCK2 inhibition. Our results
contrast with ROCK pro-invasive function in other cancers, stress-
ing that the molecular mechanism of metastatic spread likely
depends on tumour types and invasion mode.
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Introduction
With 90% of cancer patients succumbing from their metastases,
there is a pressing need to understand the mechanisms of cancer cell
dissemination (Ferlay et al 2015). Worsening patient prognosis and
impacting medical treatments, the transition from in situ to invasive
tumours is a crucial step in the metastatic progression that is trig-
gered by the acquisition of migratory properties.
Cancer cell invasion has long been considered as a single-cell
process (Valastyan & Weinberg, 2011) as observed in leukaemia, in
loosely organized tissues like sarcomas, or in highly cohesive carci-
nomas that have undergone an epithelial-to-mesenchymal transition
(EMT) (Friedl & Alexander, 2011). Activated by specific transcrip-
tion factors (EMT-TFs), Twist, Zeb, Snail and Slug, the EMT
programme promotes mesenchymal cell invasion, but also increases
stemness and survival, all contributing to cancer development and
metastatic progression (Thiery et al, 2009; Puisieux et al, 2014).
Recently, mice models of breast and pancreas cancers have shown
that EMT activation contributes to chemoresistance but is dispens-
able for metastases formation (Fischer et al, 2015; Zheng et al,
2015a). The participation of EMT-TFs and individualized dedifferen-
tiated single cells to cancer metastatic dissemination is therefore
highly debated (Nieto et al, 2016; Aiello et al, 2017; Krebs et al,
2017; Ye et al, 2017).
Cancer cell clusters can also invade as cohesive groups, a process
called collective invasion. First observed from primary tumour
explants over 20 years ago (Friedl et al, 1995), the collective inva-
sion of cancer cells has been confirmed over the past decade by
intravital microscopy in a variety of experimental model systems
(Friedl, 2004; Alexander et al, 2008; Giampieri et al, 2009) and the
systematic prospective analysis of primary tumour explants (Zajac
et al, 2018). Yet, the cellular and molecular mechanisms underlying
this process have been poorly investigated and most of our knowl-
edge is based on the collective migration driving the embryonic
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development of model organisms. The front-rear polarization of the
moving cohort translates into distinct cells, the leaders and the
followers, cooperating to tract the collective (Haas & Gilmour, 2006;
Wang et al, 2010). The leaders, protrusive cells at the front, respond
to extracellular guiding cues and adhere to the matrix to generate
traction forces. They are either defined by their closest position rela-
tive to the chemokine gradient, such as in drosophila border cells or
mammalian vascular sprouting (Duchek et al, 2001) or by the
expression of a transcriptional programme pre-existing to the migra-
tion process such as in zebrafish lateral line (Haas & Gilmour, 2006;
Aman & Piotrowski, 2008) and in breast and lung carcinoma models
(Cheung et al, 2013; Westcott et al, 2015; Konen et al, 2017).
As central regulators of the cytoskeleton, the small GTPases of
the Rho family and their regulation by guanine nucleotide exchange
factors (GEFs) and GTPase activating proteins (GAPs) play impor-
tant functions in all modes of cell migration (Ridley, 2015). The
balance between endogenous RhoA and Rac1 activities regulates the
switch between the mesenchymal and the amoeboid mode of single-
cell invasion (Sahai & Marshall, 2003; Wolf et al, 2003; Sanz-
Moreno et al, 2008). The GEFs and GAPs balancing the activation of
these small GTPases vary with cell types, and many of them have
been shown to participate in invasion (Tsuji et al, 2002; Ohta et al,
2006; Even-Ram et al, 2007; Sanz-Moreno et al, 2008). Rho-
GTPases activities were also shown to be crucial in leader cell and
at the cell–cell junctions of collectively moving cells. Tissue-specific
GEFs control the polarized activation of either Rac1 or Cdc42 in
leader cells in vitro and in vivo (Osmani et al, 2006, 2010; Bianco
et al, 2007; Migeotte et al, 2010; Wang et al, 2010; Ellenbroek et al,
2012; Cai et al, 2014; Omelchenko et al, 2014; Westcott et al, 2015;
Yamaguchi et al, 2015). In contrast, the collective invasion of
tumour spheres with inverted polarity (TSIPs) in hypermethylated
colorectal carcinomas is independent of Rac1 and protruding leader
cells (Zajac et al, 2018). In follower cells, the level of RhoA-GTP is
tightly controlled at cell–cell contacts in order to relax the junctions
while maintaining the communication and the cohesion of the group
during the migration (Omelchenko & Hall, 2012; Omelchenko et al,
2014; Reffay et al, 2014; Zaritsky et al, 2017).
With 1 million new cases worldwide per year, colorectal carci-
noma (CRC) is an important public health issue. CRCs develop
through a series of genetic, genomic and epigenetic events along
two distinct pathways: the CpG islands methylator phenotype
(CIMP) generates microsatellite instability (MSI-high) or not (MSS
or MSI-low) and gives rise to different histological subtypes, includ-
ing mucinous and micropapillary CRCs (Yamane et al, 2014). The
chromosomal instability pathway (CIN) is initiated by APC loss of
function and leads to numerous chromosomes losses and amplifi-
cations (Pino & Chung, 2010). This neoplastic transformation is
associated with the most common histological form of CRCs, named
“Lieberkuhnian” (LBK) or “not otherwise specified” (NOS). Large-
scale transcriptomic analyses have defined the consensus molecular
subtypes (CMSs) of CRCs, and one of the four groups is associated
with poor patient prognosis and mesenchymal signature (Guinney
et al, 2015). However, immunostaining of patient specimens and
data collected from patient-derived xenografts support that the
upregulation of mesenchymal genes actually occurs in the stroma
rather than in the tumour through EMT activation (Calon et al,
2015; Matano et al, 2015; McCorry et al, 2018). Histological studies
proved that tumour budding (clusters of 5 tumour cells or less) at
the invasive front is an independent prognostic factor for CRC
patients survival (Prall et al, 2005). Yet, the 3D reconstruction of
tissue sections revealed that virtually all tumour buds are connected
to the main tumour mass and it is impossible to assess whether they
represent a reservoir of migratory cells moving as small unit or
releasing individuals (Bronsert et al, 2014; Enderle-Ammour et al,
2017). Xenografted mice models of CRC have shown that silencing
Zeb1 reduces metastases formation (Spaderna et al, 2008; Wellner
et al, 2009). In contrast, transgenic mice expressing Fascin, a WNT/
b-catenin target gene, show that collective invasion also mediates
CRC spread (Vignjevic et al, 2007). Therefore, the restriction of
histological approaches based on fixed 2D cancer specimens and
molecular analyses that cannot distinguish between tumour and
stromal compartment have been unable to resolve the invasive
behaviour of human CRCs. In this study, we monitored live cancer
specimens ex vivo and identified that NOS colorectal adenocarcino-
mas predominantly undergo collective invasion in the form of dif-
ferentiated epithelial glands. We then investigated how Rho-
GTPases signalling triggers the formation of leader cells to promote
the migration of these differentiated neoplastic cell cohorts.
Results
Conventional colorectal adenocarcinomas undergo
collective invasion
To determine the mode of invasion involved in the early step of
conventional (NOS) colorectal adenocarcinoma dissemination, we
first analysed formalin-fixed paraffin-embedded (FFPE) surgical
specimens from 16 human primary tumours that have invaded the
submucosa (NOS, stage pT1, see Fig EV1A for patients, Fig EV1B
for tumour characteristics and Fig 1Ai for a representative example).
E-cadherin localized at cell–cell contact of both normal and trans-
formed epithelial cell sheets (Fig 1Aii and iii and Fig EV1C). This
staining highlighted the epithelial glandular organization of the
neoplastic tissue, including the invasive front, with cohesive cancer
cells surrounding a small luminal space (Fig 1Aii and iii). Between
▸Figure 1. Colorectal adenocarcinomas organize as cohesive and polarized epithelial glands.A Representative specimen of colorectal (CRC) primary tumour stained with haematoxylin/eosin/saffron (HES), or antibodies against E-cadherin or vimentin. (i) The blue,
orange and pink dotted lines highlight the normal mucosa, the submucosa and the muscularis propria, respectively. Red dotted line highlights the neoplastic tissue.
Black arrowheads indicate the direction of invasion. Boxed regions ii and iii show high magnification of normal colonic glands (ii) and the CRC invasive front (iii).
Scale bar: 2 mm and 500 lm.
B Representative images of histological sections of normal colon and primary CRC stained for EpCam and Villin. Boxed regions i, ii and iii are high magnifications of the
luminal cavity of normal colonic gland (i) and colorectal carcinoma glands (ii and iii). Arrow heads point to the apical pole enriched in villin. Scale bars: 50 lm.
C Graph presenting the percentage of the tumour area displaying a glandular architecture from a cohort of 16 patients (see Fig EV1).
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these neoplastic glands, stromal cells display a robust vimentin
staining (Vim(+), Fig 1Aii and iii). Although we do not exclude that
some Vim(+) cells could be CRC cells that have completely lost E-
cadherin expression and localize among the normal stromal cells,
most of the tumour is organized as a cohesive tissue with E-
cadherin-based junctions. This architecture suggested that CRCs
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may maintain their differentiated features and apico-basolateral
polarity during invasion. In support to this, immunostaining
revealed the polarized localization of the apical marker villin at the
plasma membrane facing the luminal cavity of normal and trans-
formed epithelial glands (Fig 1B, arrowheads). The cell–cell adhe-
sion molecule EpCam is excluded from the apical membrane and
rather localizes at the basolateral compartment in contact with adja-
cent cancer cells and the basal lamina (Fig 1B). Histological assess-
ment by pathologists revealed that in 87% of the patients (14/16),
more than 75% of the tumour surface organized as glandular struc-
ture (Figs 1C and EV1B and C). This shows that tumour cells at the
invasive front of pT1 colorectal adenocarcinomas maintain their
cohesion and epithelial identity, preferentially organizing as glandu-
lar structures in the peritumoral stroma.
The presence of differentiated neoplastic cell cohorts at the inva-
sive front could either result from single-cell invasion and sequential
EMT and MET activation or from the collective migration of trans-
formed tissues. To assess the dynamic invasive behaviour of
colorectal adenocarcinoma, we monitored live tumour specimens by
videomicroscopy. We retrieved primary tumour and metastases
explants for 10 patients (Fig EV2A) the day of the cytoreductive
surgery and immediately embedded them into tridimensional (3D)
gel made of extracellular matrices (ECM). Four days after recovery,
we performed time-lapse imaging during 48 h and stained for actin
and ezrin at end point. CRC histotype assessment indicated that 2
out of 10 patients had mucinous CRC, correlating with the inverted
apico-basolateral polarity of the explants we observed ex vivo and
consistent with our previous study (Zajac et al, 2018) (Figs EV2A
and EV2B, patients #E and #H, excluded from the present study
focusing on NOS adenocarcinomas). For all patients with adenocar-
cinoma (8/8), all tumour explants remained cohesive and most
displayed one or multiple lumens (77.7  6.3% and 81.6  4.9%
visualized by DIC or ezrin staining, respectively, Figs 2A and B,
EV2C and D). We very rarely saw the detachment of single cells
(not shown) and rather observed evident collective behaviour with
cell groups protruding into the collagen-I gel (Fig 2C and D and
Movie EV1). An average of 14  4% of the explants harboured
prominent actin-rich protrusions (Fig 2A arrows and 2C), contrast-
ing with the smooth periphery of the non-invasive ones (Fig 2A (ar-
rowheads), Fig EV2E and Movie EV2). The proportion of protruding
explants varies between patients, ranging from 0 to 35%, but we
did not detect a significant difference between primary tumours and
metastases (Fig 2C). The polarized morphology of the invading
gland, with protruding cells harbouring the features of leaders, is
not an ex vivo artefact from experimental procedures. Indeed, micro-
scopic study of colorectal adenocarcinoma specimens obtained from
the invasive margins by serial semi-thin sections, complemented by
electron microscopy, showed that the highly organized state of dif-
ferentiated neoplastic glands is disrupted focally in “tubular inva-
sion poles” which appears to be the leading edge of invading glands
(Fig 2Ei). In the fully formed parts of the neoplastic glands, the
epithelia are polarized and abut a basal membrane resembling
normal crypts (Fig 2Ei arrowheads and Fig 2Eii). However, at the
invasion pole, the basal membrane is missing and “leader” epithe-
lial cells form villiform cytoplasmic extensions in direct contact with
the extracellular matrix (Fig 2Ei arrows and Fig 2Eiii). Taken
together, the results we obtained from the analyses of fixed and live
human primary cancer specimens revealed that NOS CRC maintain
their apico-basolateral polarity and epithelial architecture as they
collectively invade into the submucosa in the form of neoplastic
glands. The focal formation of protruding leader cells seems to be
the starting points for this process.
ROCK inhibition triggers collective invasion from Caco-2 cysts
To investigate the signalling pathways regulating adenocarcinoma
collective invasion, we first sought an in vitro experimental model
system that recapitulates the features we observed from tumour
explants. We grew the CIN CRC cell line Caco-2 in 3D ECM gel.
Immunostaining for the apical marker prominin-1 and F-actin
revealed that Caco-2 cysts are formed by a polarized monolayer of
cells surrounding a central lumen as seen in patients’ specimens.
Over 90% of Caco-2 cysts harbour a smooth periphery due to the
absence of protruding cells (Fig 3A, left panel, Movie EV3). As
such, Caco-2 cysts grown in 3D matrices represent a pertinent
organotypic model of non-invasive NOS adenocarcinoma, allowing
gain-of-function studies to decipher the mechanisms triggering
glandular collective invasion. To this end, we performed a siRNA-
based screen targeting the RhoGTPase signalling pathway, central
to all modes of cell motility. We transfected Caco-2 cells using a
siRNA library targeting the 98 known human RhoGTPase effectors.
Accounting for functional redundancy between homologs, we co-
depleted the closest pair of proteins (Table EV1). We verified that
the co-transfection of two siRNAs does not hinder the depletion of
each protein (data not shown). The screen yielded three hits:
Caco2 cysts transfected with siPARD6A+PDE6D developed a
◀ Figure 2. Colorectal adenocarcinomas explants undergo collective invasion.A Representative confocal images of non-invasive or invasive human colorectal cancer explants collected from 8 patients with NOS adenocarcinoma (Fig EV2A and
B). The explants were fixed 4 days after recovery and stained for the lumen (ezrin), F-actin (Phalloidin) and nuclei (DAPI). Boxed regions i, ii, iii and iv are displayed
at high magnification. Arrowheads point to non-protruding cells, arrows point to protruding cells, and white stars show off-centred nuclei. Scale bars: 20 lm.
B, C Graphs representing the percentage of adenocarcinoma explants displaying lumens (B) or protrusions (C) from eight patients. Evaluation performed from DIC
observation of live tissues, at least 50 explants were analysed per patients. The error bar represents the standard error of the mean (means  SEM). P values were
calculated using unpaired t-test (ns: non-significant).
D Time-lapse sequences of an adenocarcinoma explant undergoing collective invasion into collagen-I gel monitored by DIC microscopy over 2 days (corresponding to
Movie EV1). Arrowheads point to non-protruding cells, arrows point to protruding cells, and white stars point to lumens. Scale bars: 50 lm.
E Images of an invading gland of a colorectal NOS adenocarcinoma, at the light microscopic level (i, semi-thin section, 100× objective), and as seen by electron
microscopy (ii, 1,000× magnification; and iii, 4,000× magnification). Note that the bulk of the invading neoplastic gland is in a state of glandular organization
(regions denoted by arrowheads in the left panel): epithelia (E, middle panel) are polarized to form a lumen (L) and are attached to a basal membrane (asterisk) by
hemidesmosomes; the gland is surrounded by fibroblasts (F). However, this organization is focally disrupted at the tubular invasion pole (arrows in the left panel)
where neoplastic epithelial cells have lost polarization and directly contact the surrounding stroma as the basal membrane is missing (right panel).
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multi-lumen phenotype (consistent with previous report; Durgan
et al, 2011) and siPLXNA1+siPLD1 gave defective lumens (not
shown). Caco-2 cysts co-depleted for ROCK1 and ROCK2 displayed
a supracellular polarization: a subset of protruding cells, usually
two neighbours, get off-centred but remained attached to the cyst
(Fig 3A, middle panels, arrows). Their nuclei lost the alignment
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with the monolayer and engaged into protrusion (Fig 3A, middle
panel, stars). In a validation round, Z-stacks acquisition of Caco-2
cysts transfected with siROCKs further demonstrated that the
bulging cells formed actin-rich protrusions towards the ECM gel
(Fig 3A (right panels, arrows) and Fig EV3A), while the rest of the
cohort did not (Fig 3A, arrowheads). These protruding morphol-
ogy and supracellular polarization of Caco-2 cysts transfected with
siRNA targeting ROCK resemble the collective invasion pattern
observed form the CRC explants (Fig 2A). To confirm this result
and exclude an off-target effect of the siRNAs, we used alternative
reagents. First, we transduced Caco-2 cysts using shRNAs against
ROCK1 and ROCK2 (Fig EV3B). This induced a 10-fold increase in
the number of cysts with protruding cells, raising from 6  1% to
60  1%, demonstrating the phenotype was specific to ROCK
depletion (Fig 3B and C). We then used pharmacological inhibitors
Y27632 and H1152 to determine whether ROCK kinase activity
was sufficient to control this phenotype. Treatment with Y27632
and H1152, respectively, increased the number of protruding cysts
from 7  2% to 56  3% and 63  2% (Fig 3B and C). Using live
imaging, we confirmed that the “leader/follower” polarization of
Caco-2 cysts treated with ROCK inhibitors Y27632 and H1152
resulted from the neoformation of protrusions, as observed from
patient explants (Fig EV3C). E-cadherin staining confirmed that all
cells of the cohort remained cohesive and that the luminal cavity
was conserved (Fig 3B).
To determine whether the “leader/follower” polarization of
protruding Caco-2 cysts efficiently translates into invasion, we
adapted the Boyden chamber to 3D organotypic cultures. The
membrane was coated with Matrigel, and Caco-2 cells were grown
as cysts in 3D gels in the top chamber. To allow chemotactism, a
serum gradient was established from the bottom chamber (Fig 3D).
In this new assay, we evaluated the ability of Caco-2 cells to invade
from the top to the bottom chamber of the Transwell. The number
of cells that have invaded was analysed by automated segmentation
and quantification 3 days after induction of the serum gradient. As
expected for a non-invasive CRC model, very few Caco-2 cells
reached the bottom chamber in control condition. In contrast,
treatment with Y27632 and H1152 or transfection of siROCKs
increased by 9.3  1.9-, 8.7  1.1- and 8.5  2.7-fold, respectively,
the number of cells reaching the bottom chamber (Fig 3E).
Immunostaining of the top and bottom side of the membrane using
antibodies against E-cadherin, ZO-1 and ezrin demonstrated that
Caco-2 cells remain cohesive in both compartments (Fig 3F). In
support to this, we did not detect any change in the expression level
of epithelial (E-cadherin and keratins) and mesenchymal (N-
cadherin and vimentin) markers, showing that the acquisition of the
invasive phenotype occurs independently of the activation of an
EMT programme (Fig EV3D). Hence, inhibiting ROCK kinase activ-
ity is sufficient to trigger protruding activity and collective invasion
from Caco-2 cysts.
Inhibiting ROCK activity augments collective invasion from
colorectal adenocarcinoma explants
To confirm ROCK function, we first examined whether pharmaco-
logical inhibitors could affect the invasion of organoids made from
patient-derived xenograft (PDX) embedded into collagen-I gels. The
organoids from CRC NOS adenocarcinoma form glandular structures
characterized by cohesive cells (highlighted by E-cadherin staining)
and apico-basolateral polarity (highlighted by the central lumen,
Fig 4A) as previously described (Sato & Clevers, 2013). While in
basal conditions, only 7  1% of these organoids harboured protru-
sions, treatment with Y27632 and H1152 increased the number of
protrusive structures to 78  4.6% and 93  2.2%, respectively
(Fig 4A and B). Next, we treated explants freshly retrieved from
CRC patients with ROCK inhibitors. As described above, primary
specimens were collected from patients (Fig EV2A) at the time of
surgery and embedded into ECM gels. Treatment with these inhibi-
tors did not affect the epithelial architecture of the CRC explants as
shown by the presence of luminal cavities (Fig 4C, D and F and
Movie EV3). Strikingly, Y27632 and H1152 triggered protrusions
formation, increasing the number of invasive structures from
14  4% to 63  6% and 57  5%, respectively (Fig 4E and F and
Movie EV3). We observed similar phenotypes from explants
◀ Figure 3. ROCK inhibition induces the collective invasion of Caco-2 cysts.A Representative images of Caco-2 cysts transfected with control siRNA (siGlo) or siRNAs targeting ROCK1 and ROCK2, fixed and stained for prominin-1, F-actin
(Phalloidin) and nuclei (Hoechst). Confocal Z-sections of cysts are displayed. Arrowheads show non-protruding cells. Arrows point to protruding cells. White stars
mark nuclei that are off-centred relative to the cyst’s monolayer. Scale bars: 20 lm.
B Representative confocal images of Caco-2 cysts treated with ROCK inhibitors Y27632 and H1152, non-treated (NT) or transduced with ROCK1 and ROCK2 shRNAs
(shROCK1+2). The cysts were fixed 2 days after invasion and stained for E-cadherin, F-actin (Phalloidin) and nuclei (DAPI). Boxed regions i and ii are displayed at high
magnification. White arrowheads point to non-protruding cells, green arrowheads point to the apical pole, arrows point to protruding cells, and white stars show off-
centred nuclei. Scale bar: 20 lm.
C Bar graph representing the percentage of protrusive Caco-2 cysts from three independent experiments. Caco-2 cysts non-treated (NT), incubated with ROCK inhibitors
Y27632 and H1152 or infected with lentiviruses encoding shRNA control and targeting ROCK1 and ROCK2. The cysts were fixed 2 days after invasion; over 100 cysts
were counted for each condition. Error bar represents the standard error of the mean (means  SEM). P values were calculated using unpaired t-test (***P < 0.001,
**P < 0.01).
D (Left panel) Schematic representation of the 3D Boyden chamber invasion assay. The Caco-2 was grown as cysts in 3D Matrigel on the top chamber of the Boyden for
3 days, and then, the serum gradient was induced. Two days after, the nuclei of the cells that have reached the bottom side of the membrane were stained with
Hoechst and quantified by automated acquisition and segmentation. (Right panel) DIC image of the membrane facing the top chamber reveals the cysts and the
immunofluorescence image of the membrane facing the bottom chamber stained with Hoechst reveals the cells that have invaded.
E The number of cells that have invaded from the top to the bottom chamber of the Boyden chamber was quantified by automated segmentation in non-treated (NT),
in ROCK inhibited conditions (Y27632, H1152) or in cells transfected with siRNA against ROCK1 and ROCK2 (siROCK1+2). The number of cells that have invaded was
normalized to control conditions and reported as the average invasion rate from at least three independent experiments (means  SEM). P values were calculated
using unpaired t-test (****P < 0.0001, **P < 0.01).
F High magnification of boxed region from (D). The top (i) and the bottom (ii) side of the Boyden chamber membrane was stained for F-actin, E-cadherin, ZO-1, ezrin
and Hoechst. Arrow points to the protrusive cells of an invasive cyst, and the white stars show the nuclei that engage in the protrusion. Scale bars: 40 lm.
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retrieved from primary tumours or metastases (not shown), and the
invasion capacities were not associated with KRAS mutations status
(Fig EV2A). Altogether, our results demonstrate that the inhibition
of ROCK activity triggers the protrusive activity of NOS adenocarci-
noma explants, organoids and cell lines to induce their collective
invasion.
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ROCK2 inhibition is sufficient to induce collective invasion
To differentiate the respective contribution of ROCK1 and ROCK2,
we separately silenced the kinases in Caco-2 cysts and assessed for
invasion (Fig EV3A). The depletion of ROCK1 did not increase the
formation of protruding leader cells. In contrast, depletion of ROCK2
triggered the formation of invasive cysts, increasing from 6  1% to
53  6%, equivalent to the co-depletion of both kinases and the
treatment with Y27632 (Fig 5A and B). To investigate the role of
ROCK2 kinase activity in collective invasion, we generated domi-
nant negative mutants (DN), ROCK2DN#1 and ROCK2DN#2, as
previously described (Amano et al, 1999). They correspond to the
carboxy-terminal region of ROCK2 which includes the Rho binding
(RB) and the Pleckstrin homology (PH) domains. Both constructs
are predicted to bind ROCK2 catalytic domain, thereby competing
with its substrates (and the ROCK2DN#2 harbours a point mutation
in the RB domain to prevent the titration of RhoA-GTP). We tested
their ability to interact with endogenous ROCK proteins in our Caco-
2 cells. Protein complexes were immunoprecipitated using GFP-
trap beads from lysates expressing GFP-tagged ROCK2 DN
constructs. Western blot revealed that GFP-ROCK2DNs interact with
endogenous ROCK2, but not ROCK1 (Fig EV3E). When stably
expressed in Caco-2 cells, ROCK2DN#1 perturbed Caco-2 cyst
morphogenesis (as expected if it titrates RhoA-GTP) but mutation of
the RB domain in ROCK2DN#2 allowed the formation of normal
cysts with a single central lumen (Fig EV3F). We therefore only
used the stable cell line expressing ROCK2DN#2 in our invasion
assay. Expression of this construct increased the protrusion rate of
Caco-2 cysts from 11  1% to 51  1% (Fig 5C and D). Then, to
address whether ROCK2 activity was sufficient to restrain migratory
behaviours, we used the T84 cysts that provides a pro-invasive
model of colorectal adenocarcinoma. T84 cysts display a glandular
organization with over 60% of them undergoing spontaneous
collective invasion at steady-state or after transduction with GFP
(Fig 5E and F). Treatment by Y27632 further increased T84 invasive
cysts to 93  3%. Conversely, expression of dominant active
ROCK2 (ROCK2-DA), corresponding to the catalytic domain of the
kinase, reduces the number of protruding T84 cysts to 35.8  9%
(Fig 5E and F). Finally, to evaluate the clinical significance of our
findings, we examined the correlation between the level of ROCK2
or ROCK1 mRNA and the survival of CRC patients using Kaplan–
Meier analysis. Decreased level of ROCK2 expression (from two
independent probes), but not ROCK1, significantly correlated with
shorter overall patient survival (Fig 5G). Taken together, these
results demonstrate that ROCK2 activity prevents collective invasion
from colorectal adenocarcinoma ex vivo and its decreased expres-
sion is correlated with poor patient prognosis.
ROCK2 inhibition promotes leader cell formation
We then investigated the mechanism of ROCK function. Inhibition
of the kinase activity triggers the supracellular polarization of Caco-
2 cysts resulting in the appearance of protrusive leader cells and
non-protrusive followers. We reasoned that ROCK2 inhibition could
either directly induce the formation of leaders or followers, or, alter-
natively, unleash cysts that include cells with a pre-existing leader
fate. To examine this, we generated mosaic cysts to inhibit ROCK2
activity in a small subset of cells (Fig 6A). Mature Caco-2 cysts were
transduced using a sub-optimal concentration of lentiviral particles
encoding GFP-ROCK2DNs in order to target only 1 or 2 cells per
cyst. Strikingly, the acute mosaic expression of ROCK2DN#2
increased the invasion to 74% (Fig 6B and C). We then measured
whether ROCK2DN#2 expressing cells become leaders or followers.
In control cysts treated with Y27632, 34.6  5.5% of cells express-
ing GFP became leader cells. In contrast, 79.9  3.9% of cells
expressing ROCK2DN#2 were protrusive leaders (Fig 6D).
In other model systems, the small GTPases Rac1 controls F-actin
polymerization in leader cells (Wang et al, 2010; Yamaguchi et al,
2015). We therefore reasoned that Rac1 could participate in leader
cell formation in CRCs. To verify this hypothesis, we first used the
CRIB domain of PAK to pull-down GTP-bound Rac1 in cell treated
with the ROCK inhibitors. Western blot analyses revealed an
increase in the level of Rac1-GTP after the treatment by Y27632 and
H1152, with a few hours shift in the kinetic (12 and 16 h, respec-
tively, Fig 6E). Then, we co-treated Caco-2 cysts with Y27632 or
H1152 and the Rac inhibitor NSC23766 during our organotypic inva-
sion assay. The treatment with NSC23766 decreased the number of
protrusive cysts induced by Y27632 or H1152 treatment from
32  1% to 14  4% and 8  1%, respectively (Fig 6F and G).
These results demonstrate that there is not leader cell fate prede-
termination in Caco-2 cysts and the inhibition of ROCK2 activity is
sufficient to promote the formation of protrusive leaders down-
stream of Rac1 activation.
Caco-2 cyst invasion relies on FARP2 a GEF for Rac1
We then aimed at identifying the effectors of ROCK2 involved in
Caco-2 cysts collective invasion. To identify the GEF mediating the
◀ Figure 4. ROCK inhibition promotes the collective invasion of colorectal adenocarcinoma explants.A Representative images of organoids formed from patient-derived xenografts (PDXs) that have been embedded in collagen-I gels during 3 days, in non-treated (NT)
or ROCK inhibitors-treated conditions (+Y27632) and (+H1152). At end point, organoids were stained for E-cadherin, F-actin (Phalloidin) and nuclei (DAPI). i and ii
are high magnification of boxed regions of +Y27632 and +H1152 organoids, respectively. Arrows point to protruding cells. White stars show nuclei that engage in
protrusions. Scale bars: 20 lm.
B The bar graph represents the percentage of protrusive organoids resulting from three independent experiments. Over 50 organoids were counted per condition
(means  SEM). P values were calculated using paired t-test (***P < 0.001).
C Representative images of human adenocarcinoma explants after 2 days in 3D collagen-I gel, in non-treated (NT) or ROCK inhibitors-treated conditions (+Y27632)
and (+H1152) and stained for the apical pole (ezrin), F-actin (Phalloidin) and nuclei (DAPI). Boxed regions of NT, +Y27632 and +H1152 explants are shown at high
magnification. Arrowheads point to non-protruding cells. Arrows point to protruding cells. White stars show nuclei that engage in protrusions. Scale bars: 20 lm.
D, E Explants displaying (D) lumens or (E) protrusive cells from 10 patients were quantified and results presented as percentage of total explants. Over 50 explants were
counted per condition (duplicate) and per patient (means  SEM). P values were calculated using unpaired t-test (****P < 0.0001, n.s : non-significant).
F Time-lapse sequences of an adenocarcinoma explant undergoing collective invasion into collagen-I gel in the presence of Y27632 monitored by DIC microscopy for
2 days (corresponding to Movie EV3). Arrowheads point to non-protruding cells, arrows point to protruding cells, and white stars point to lumens. Scale bars:
50 lm.
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activation of Rac1 downstream of ROCK inhibition, we used a
siRNA-based screen in the adapted Boyden chamber assay
(Fig 3D). For this, we transfected Caco-2 cells with a siRNA library
targeting all known GEFs of the human genome and assessed
collective invasion induced by Y27632. To prevent any functional
redundancy, we grouped the siRNA targeting the two closest
homologs (Table EV2). The screen yielded 3 hits decreasing the
invasion rate by threefold or more (Fig 7A). Two of the hits,
targeting GEFs for RhoA and RhoG, were not confirmed in the
validation round. The third hit, combining siRNA against FARP1
and FARP2, two GEFs for Rac1 and Cdc42, decreased by
3.8  0.1-fold the rate of invasion induced by Y27632 (Fig 7A,
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Pair#24) (He et al, 2013). To confirm these results and determine
whether both FARP homologs participate in collective invasion,
we independently depleted FARP1 or FARP2 using specific shRNAs
and verified this did not perturb Caco-2 cystogenesis (Fig EV4A
and B). Silencing FARP2 using two independent hairpins reduced
the number of protruding Caco-2 cysts induced by Y27632 from
58  6% to 25  6% and 32  4%, respectively, while FARP1
depletion had no effect (Fig 7B and C). Depleting FARP2 in the
pro-invasive T84 cysts reduced protrusion formation from
51  7% to 33  7% and 39  9%, respectively, confirming that
this pathway is conserved across colorectal adenocarcinomas
models (Fig EV4C). We confirmed that FARP2 is a GEF for Rac1
using GST-PAK pull-down after overexpression or shRNAs treat-
ment and showed its activity is inhibited by the NSC23766
(Figs EV4D and 4E). Then, we asked how ROCK was regulating
FARP2 activity. We could not co-immunoprecipitate overexpressed
ROCK2 and FARP2 constructs or detect by Western blot any band
shift suggestive of phosphorylation, implying that FARP2 is not a
ROCK2 substrate (Data not shown). In support to this, FARP2 is
not part of the ROCK substrate candidates identified by proteomic
analyses (Amano et al, 2015). Instead, ROCK2 could indirectly
regulate FARP2 by controlling its localization. To test this hypoth-
esis, we examined the subcellular distribution of the proteins in
Caco-2 by immunofluorescence. Endogenous ROCK2 localizes in
the nucleus and at the apical junctional complex (AJC), while
GFP-FARP2 associates with the basolateral membrane but is
largely excluded from the AJC (Fig EV5A, top row). To evaluate
whether ROCK activity could affect FARP2 recruitment at the AJC,
we expressed GFP-FARP2-FL protein in 2D Caco-2 cells and
treated with Y27632 or H1152. Both ROCK inhibitors promoted
GFP-FARP2 recruitment at the AJC (stained with ZO-1 antibodies),
which could be visualized by linescan measurement (Fig 7D and
E). Quantitative analyses demonstrated that the FARP2/ZO-1 fluo-
rescence intensity ratio increases by 23 and 32% after treatment
with Y27632 and H1152, respectively (Fig 7F).
Taken together, the results support that the GEF FARP2 is a
downstream effector of ROCK2 necessary for the collective invasion
of Caco-2 cysts. ROCK2 does not directly phosphorylate FARP2;
however, it prevents its localization at the AJC.
FARP2 activation and Myosin-II inhibition cooperate to induce
collective invasion downstream of ROCK2 inhibition
Finally, we examined whether FARP2 was sufficient to induce
collective invasion in Caco-2 cysts. Intriguingly, overexpressing
GFP-tagged FARP2-FL did not induce the formation of protrusions
(Fig 8A and B). Since FARP2-FL may be folded in an inactive
conformation, we generated activated mutants harbouring point
mutations on residues 730 and 733 (FARP2-Mut), a truncation of
the PH2 domain (FARP2-del) or both (FARP2-del/Mut, Fig EV5B)
(He et al, 2013). We could not detect any significant changes in the
cysts expressing FARP2 activated mutants as compared with the
cysts overexpressing FARP2-FL or GFP alone (Fig 8A and B). Since
FARP2 activation was not sufficient to induce protrusive activity,
we hypothesized that another effector of ROCK2 could participate in
the regulation of collective invasion. To address whether Myosin-II
was involved, we first inhibited the motor activity of Myosin-II by
treating Caco-2 cysts with blebbistatin. Some cells formed long and
thin F-actin-rich elongations resembling dendrites. This “dendritic”
phenotype was very different from the broad protrusions produced
by leader cells under ROCK2 inhibition, and we did not detect any
engagement of the nuclei towards this structure (Fig 8C and D). We
then used siRNAs to assess whether other functions of Myosin-II,
such as the F-actin cross-linking activity (Vicente-Manzanares et al,
2009), could participate in the regulation of collective invasion. The
depletion of Myosin-IIA, but not Myosin-IIB, reproduced the pheno-
type induced by blebbistatin but failed to induce leader cell forma-
tion (Fig 8C and D and EV5C). We finally checked whether Myosin-
II and FARP2 could cooperate, downstream of ROCK, to control
collective invasion. We performed a dose–response experiment to
identify the sub-optimal concentration of blebbistatin that did not
induce the “dendritic” phenotype (Fig EV5D). We further combined
blebbistatin at this concentration with the expression of FARP2
constructs and assessed for protrusion formation. Expressing
FARP2-FL or the activated mutants of FARP2 in combination with
10 lM of blebbistatin increased the formation of invasive cysts from
13  6% to 59  6%, 50  14% and 45  6%, respectively
(Fig 8E and F). Thus, FARP2 can induce the formation of leader
cells solely when the acto-myosin cytoskeleton is relaxed.
◀ Figure 5. ROCK2 inhibition is necessary and sufficient to control collective invasion.A Caco-2 cysts expressing an empty vector (pLKO) or shROCK1 (#02) or shROCK2 (#36) after 2 days of invasion were fixed and stained for E-cadherin, F-actin
(Phalloidin) and nuclei (DAPI). Boxed regions i, ii and iii are shown at high magnifications. Arrowheads point to non-protruding cells. Arrow points to protruding cells.
White stars show nuclei that engage in protrusions. Scale bars: 20 lm.
B The number of protrusive Caco-2 cysts was quantified in each of the mentioned conditions and represented in a bar graph as percentage of total cysts
(means  SEM of at least 3 independent experiments, paired t-test, ***P < 0.001, *P < 0.05 n.s: non-significant).
C Caco-2 cysts stably expressing GFP alone or GFP-ROCK2DN#2 were submitted to a 2 days period invasion assay, then fixed and stained for F-actin (Phalloidin) and
nuclei (DAPI). Boxed regions i, ii and iii are shown at high magnification. Arrowheads point to non-protruding cells. Arrows point to protruding cells. White and black
stars show nuclei that engage in protrusions. Scale bars: 20 lm.
D Bar graph representing the percentage of protrusive cysts transduced with GFP (CTRL, with or without Y27632) or with ROCK2DN#2 (means  SEM of at least 3
independent experiments, paired t-test, **P < 0.01 n.s: non-significant).
E T84 cells grown in 3D organotypic culture form polarized cysts with a central lumen that display protruding leader cells at the basal pole (arrows) reminiscent of
collective invasion. T84 cysts were transduced with lentiviruses encoding inducible GFP or Venus-ROCK2-DA and treated with doxycycline 1 lg/ml. Scale bars: 20 lm.
F Bar graph representing the percentage of protrusive T84 cysts in control (WT), treated with ROCK inhibitor (Y27632) or transduced with lentiviruses expressing GFP or
Venus-ROCK2-DA after induction by doxycycline (means  SEM of at least 3 independent experiments) (paired t-test, ***P < 0.001, *P < 0.05).
G Overall survival prognostic value of ROCK2 expression in colon cancer patients of the GSE33582 data set (n = 477 patients with survival annotation) using Kaplan–
Meier survival analysis. The patient cohort was divided into tumours with or without a down-regulation of ROCK2 relatively to non-tumoural tissues (expression cut-
off value corresponds to the 1st decile of ROCK2 expression in non-tumoural sample, i.e., 7.6). Log-rank test P-values for survival distribution difference are indicated
at 3 and 5 years.
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Figure 6. ROCK2 inhibition promotes leader cell formation.
A Schematic representation of Caco-2 cyst phenotypes obtained after mosaic transduction of ROCK2DN#2.
B DIC acquisition of fixed mosaic Caco-2 cysts expressing GFP alone, GFP-ROCK2DN#1 or GFP-ROCK2DN#2. Boxed regions i and ii are shown at high magnification.
Arrowheads point to non-protruding cells. Arrows point to protruding cells. Scale bars: 20 lm.
C Bar graph representing the percentage of mosaic Caco-2 cysts transduced with GFP or GFP-ROCK2DN#, with or without Y27632, harbouring a protruding morphology
(means  SEM of at least 3 independent experiments, unpaired t-test, ***P < 0.001, *P < 0.05).
D Quantification of the fate of the GFP-positive cells, leader or follower, in mosaic cysts transduced with GFP alone and treated with Y27632 (GFP+Y27632) or GFP-
ROCK2DN#2 from 3 independent experiments (means  SEM, unpaired t-test, ***P < 0.001).
E Representative pull-down of Rac1-GTP by PAK-Crib, in Caco-2 cells treated with ROCK inhibitor Y27632, H1152 or blebbistatin and lysed at 12 or 16 h. Immunoblot
analyses were performed with anti-Rac1 and anti-GAPDH antibodies from three independent experiments.
F DIC acquisition of fixed Caco-2 cysts treated with ROCK inhibitors alone (Y27632 or H1152), or in combination with Rac1 inhibitor NSC23766. Arrowheads point to
non-protruding cells, and arrow points to protruding cell. Scale bar 20 lm.
G Bar graph representing the percentage of protruding Caco-2 cysts in control conditions (non-treated, NT) or treated with NSC23766, Y27632 or H1152 (means  SEM
of at least 3 independent experiments, unpaired t-test, ****P < 0.0001, ***P < 0.001, *P < 0.05).
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Figure 7. Caco-2 cysts collective invasion relies on the Rac-GEF FARP2.
A siRNA screen performed in Caco-2 cysts treated with Y27632: Caco-2 cells transfected with control siRNA or pairs of siRNA targeting RhoGEFs were seeded in the
modified 3D Boyden chamber (Fig 3D) and grown as cysts for 3 days. Then, Caco-2 cysts were treated with Y27632, and the serum gradient was induced. After 2 days,
the number of cells present on the bottom chamber was quantified by automated segmentation after Hoechst staining. The bar graph represents the mean invasion
rate. Each condition was duplicated. The red dashed line represents the median invasion rate; the red full line indicates the threefold decrease in invasion rate. Three
hits were identified: #2:ARHGEF18+RNEF, #7: SGEF+ARHGEF16 and #24: FARP1+FARP2 (mean SD).
B Caco-2 cysts stably expressing empty vector (pGIPZ) or 2 distinct shFARP1 or shFARP2 were treated with Y27632, allowed to invade for 2 days, fixed and stained for F-
actin (Phalloidin). Boxed regions i, ii, iii and iv are shown at high magnification. Arrowheads point to non-protruding cells; arrows point to protruding cells. White
stars show nuclei that engage in protrusions. Scale bars: 20 lm.
C Bar graphs representing the percentage of protrusive cysts formed from Caco-2 cells transduced with lentiviruses encoding pGIPZ or shRNA against FARP1 and FARP2
after treatment with Y27632 from at least 3 independent experiments (means  SEM, paired t-test, ns: non-significant, **P < 0.01).
D Representative acquisition of Caco-2 cells overexpressing GFP-FARP2 grown in 2D and stained with ZO-1, in non-treated condition (NT) or after 2 h with Y27632 or
H1152. The dashed lines crossing the cell–cell junctions (i, ii and iii) are representative of the linescans measurements. Scale bars: 20 lm.
E Representative fluorescence intensity of ZO-1 (red) staining and GFP-FARP2 (green) along the dashed line i, ii and iii represented in Fig 7D corresponding to non-
treated, Y27632 or H1152 treatments.
F Bar graph representing the average ratio of GFP-FARP2 over ZO-1 fluorescence intensities measured with linescans crossing cell–cell junctions. The quantification
was performed on 71 cells expressing GFP-FARP2-FL from three independent experiments. For each cell, between 10 and 15 lines (12 pixels wide) were drawn across
random region of cell–cell junctions positive for ZO-1 staining (mean  SEM unpaired t-test **P < 0.01, *P < 0.05).
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Figure 8. FARP2 activation and Myosin-II inhibition cooperate to induce collective invasion downstream of ROCK2 inhibition.
A Caco-2 cysts stably expressing GFP (treated or not with Y27632), or cherry-FARP2-full length (FARP2-FL), FARP2-730/733 mutant (FARP2-Mut) or FARP2 del PH 730/733
(FARP2-del/Mut) were allowed to invade for 2 days, fixed and stained for F-actin. Boxed regions i, ii, iii, iv and v are shown at high magnification. Arrowheads point to
non-protruding cells, arrow points to protruding cells, and white star shows nucleus that engages in protrusion. Scale bars: 20 lm.
B Bar graph representing the percentage of protrusive cysts expressing GFP (treated or not with Y27632) or the mentioned GFP-FARP2 constructs from 3 independent
experiments (means  SEM, paired t-test, **P < 0,01, n.s: non-significant).
C Representative images of Caco-2 cysts treated with Y27632 or blebbistatin or transfected with siRNA targeting Myosin-IIA and allowed to invade for 2 days. After
fixation, the cysts were stained for F-actin (Phalloidin) and nuclei (DAPI). Representative Y27632-induced “invasive” phenotype and blebbistatin-induced “dendritic”
phenotype are displayed. Arrow points to protruding cells, white star shows nucleus that engages in protrusion, and arrowheads point to “dendritic” protrusions.
D Bar graph representing the percentage of cysts with the “invasive” or “dendritic” phenotypes after treatment with Y27632, blebbistatin or siMyosin-IIA or siMyosin-IIB
from at least 3 independent experiments (means  SEM, unpaired t-test,*P < 0.05, n.s: non-significant).
E Mature Caco-2 cysts were transduced with GFP or cherry tagged FARP2-full length (FARP2-FL), FARP2-730/733mutant (FARP2-Mut) or FARP2 del PH/730/733 (FARP2-del/
Mut), and treated (or not, NT) with blebbistatin. 2 days after invasion, and the cysts were fixed and stained for F-actin. Boxed regions i, ii, iii and iv are shown at high
magnification. Arrowheads point to non-protruding cells; arrow points to protruding cells; and white stars show nuclei that engage in protrusions. Scale bars: 20 lm.
F Bar graph representing the percentage of protrusive Caco2 cysts expressing the mentioned constructs, treated or not with blebbistatin, from at least 3 independent
experiments (means  SEM, t-test,**P < 0.01, n.s: non-significant).
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Altogether, these results demonstrate that FARP2 activation and
Myosin-II inhibition cooperate downstream of ROCK2 to regulate
the collective invasion of colorectal adenocarcinoma models.
Discussion
Enabling invasive properties is the first step of the metastatic
cascade and a challenge to patient treatment. Based on the analyses
of fixed and live cancer explants, this study revealed that NOS CRC,
the most common type of CRCs representing about 80% of these
cancers, maintains their epithelial glandular architecture while
undergoing collective invasion to conquer the successive layers of
the digestive wall. We identified ROCK2 as an essential kinase
controlling the invasive behaviour of CRCs models such as cysts
and organoids. ROCK2 inhibition triggers the formation of leader
cells through a dual mechanism involving the reduction of Myosin-
II activity and the activation of Rac1 through the GEF FARP2 to
generate protrusive forces.
The analysis of CRC specimens collected from patients demon-
strates that the tumour remains mainly cohesive through E-cadherin-
based junctions while invading the submucosa or 3D collagen-I gels.
This is consistent with the growing body of evidences supporting the
contribution of collective behaviour to the metastatic spread of
several cancer types, from patients or mice models, at early or late
stages of cancer progression (Friedl et al, 1995, 2012; Giampieri
et al, 2009; Cheung & Ewald, 2016; Khalil et al, 2017; Konen et al,
2017; Zajac et al, 2018). While in the past decades, most of the
biomedical research investigations have focused on the EMT
programme, seen as the main driver of cancer cell dissemination
(Chaffer et al, 2016), this concept has recently been challenged by
the demonstration that pancreas and breast cancer metastases form
in mice without activation of the EMT transcription factors (Fischer
et al, 2015; Zheng et al, 2015b) or that the EMT programme is in fact
activated into the stromal component of CRCs (Kim & Verhaak,
2015). However, inhibiting EMT activation by silencing Zeb1 in CRC
cell lines transplanted into immunodeficient mice decreases metas-
tases formation (Spaderna et al, 2008; Wellner et al, 2009). These
discrepancies could be explained by inter- and intra-tumoral hetero-
geneity or cancer cell plasticity and imply that dissemination strate-
gies can be multiple and possibly complementary (Friedl &
Alexander, 2011).
Surprisingly, we found that CRCs NOS/adenocarcinoma primary
samples, organoids and cysts retain their epithelial polarity and
architecture, invading as glandular structures in vivo, into the peri-
tumoral stroma, or in vitro, in collagen-I gel. This is consistent with
the fact that 80% of CRCs are well to moderately well-differentiated
tumours (Prall et al, 2009; Fleming et al, 2012). This is a distinctive
feature among the collective invasion of cancer cells reported to
date. The apico-basolateral polarity of transformed epithelial cells is
either lost, such as in breast carcinoma, or inverted, such as in the
Mucinous or micropapillary types of CRC (Khalil et al, 2017; Zajac
et al, 2018). However, during normal development and organogene-
sis, epithelial cell cohorts undergo collective migration while main-
taining central lumens. In this case, the lumen enables growth
factors concentration or exosome transfer favouring the activation
of tyrosine kinase receptors (Durdu et al, 2014; Kwon et al, 2014;
Revenu et al, 2014). Whether the luminal cavity of CRC glands
provides a selective advantage for tumour dissemination or prolifer-
ation is an attracting area of investigation.
We found that inhibition of ROCK triggers the formation of lead-
ers and the transition from non-invasive to protrusive cohorts that
undergo collective invasion. This is in contradiction with the pro-
invasive role of ROCK identified in CIMP CRCs explants (Zajac et al,
2018), mice xenografted with cell lines (Itoh et al, 1999; Croft et al,
2004; Sadok et al, 2015) or transgenic models of pancreatic cancer
(Rath et al, 2018). However, our results are in agreement with the
recent large-scale in vivo RNAi screen revealing that loss of Myosin-
II triggers the formation of invasive skin cancers (Schramek et al,
2014) and that expression of active ROCK2 increases proliferation,
but not invasion in similar models (Samuel et al, 2011). By investi-
gating the early step of collective invasion, i.e., the transition from
quiescent to invasive glands, we have revealed the anti-invasive
activity of ROCK2, a function that may not have been identified from
cancer cells that have already gained invasive capacities. Our results
are supported by the study from Lomakin et al showing that Myosin
and ROCK inhibition triggers the migratory behaviour of non-motile
single epithelial cells (Lomakin et al, 2015). The discrepancies in the
role of ROCK in invasion could also be related to several aspects of
cancer heterogeneity. First, the histological type and/or the molecu-
lar background of cancer may influence invasion mode and ROCK
function. In line with this, ROCK has an anti-invasive role in NOS
CRCs that mostly display chromosomal instability, and a pro-inva-
sive function in MUC CRCs that arise from the CIMP pathway of
carcinogenesis (Zajac et al, 2018). In addition, crosstalk with specific
oncogenes and tumour suppressors, such as KRAS, Smad4 or JAK1,
can modify the expression level and activity of ROCK (Sahai et al,
2001; Hoogwater et al, 2010; Sanz-Moreno et al, 2011; Voorneveld
et al, 2014), yet we did not detect a significant correlation with KRAS
status in our cohort (Fig EV2A). Second, ROCK may have different
actions if the tumour spreads as individual cells or collectives. In
single cells, increased acto-myosin contractility would promote fast
amoeboid invasion, likely accelerating metastases formation (Sahai
& Marshall, 2003). In contrast, reducing cortical tension in cell
cohorts, at cell–cell junctions or the basal membrane, would be
beneficial for collective invasion (Fischer et al, 2009; Giampieri et al,
2009; Hidalgo-Carcedo et al, 2011). Third, the tissue in which the
tumour is borne may influence ROCK function and elicit different
responses to its inhibition. While interfering with ROCK and Myosin-
II activity has long been known to impede fibroblast movement,
recent work has demonstrated that it promotes the migration of
single epithelial cells (Lomakin et al, 2015).
How does ROCK2 control the invasive behaviour of CRC neoplas-
tic glands? Using the acute expression of dominant negative
mutants, we targeted ROCK2 inhibition in a restricted number of
cells within the cohort. This was sufficient to induce leader cell
formation, demonstrating that unlike breast and lung carcinomas,
CRC leaders are not predetermined by a transcriptional programme
(Cheung et al, 2013; Konen et al, 2017). Nevertheless, the activation
of specific gene expression may be induced downstream of ROCK
inhibition by mechanosensing proteins such as YAP/TAZ or Stat3
(Dupont et al, 2011; Sanz-Moreno et al, 2011). We show that ROCK
controls two distinct F-actin dynamics, F-actin polymerization
through Rac1 and F-actin contractility through Myosin-II. Rac1 acti-
vation is a common determinant of leader cell formation (Wang
et al, 2010; Yamaguchi et al, 2015). Yet, our screen targeting all
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human GEFs did not identify b bix, Tiam1 or DOCK180 that have
been previously described to activate Rac1 in collective migration
(Osmani et al, 2006; Bianco et al, 2007; Ellenbroek et al, 2012).
Although the ROCK/Rac1 balance is a core mechanism controlling
all migratory processes, the GEFs and GAPs governing their
spatiotemporal activation vary with cell types and stimuli (Sadok &
Marshall, 2014). We found that FARP2 activity was necessary for
Caco-2 collective invasion induced by ROCK inhibition, but
not FARP1. While they both regulate cytoskeleton dynamics (Kubo
et al, 2002; Toyofuku et al, 2005; Zhuang et al, 2009; Cheadle &
Biederer, 2012, 2014; Mlechkovich et al, 2014), these two GEFs
act downstream of distinct signalling pathways to control
neurite outgrowth, axon collapse, podosome formation or bone
metabolism (Koyano et al, 1997, 2001; Takegahara et al, 2010) and
only FARP2 has been reported to regulate cell motility (Miyamoto
et al, 2003).
While the photo-activation of Rac1 is sufficient to drive the
collective migration of border cells, FARP2 expression is ineffective
at triggering Caco-2 cyst collective invasion. Downstream of ROCK,
we found that relaxing acto-myosin contractility is required to
unleash collective invasion. This is in agreement with previous
reports from 2D cultures, where breaking up the supracellular
marginal actin bundle and loosening acto-myosin tension at cell–cell
junctions both contribute to collective migration (Omelchenko et al,
2003; Hidalgo-Carcedo et al, 2011; Omelchenko & Hall, 2012; Reffay
et al, 2014). In addition, releasing actin bundles frees actin mono-
mers increasing the pool of soluble G-actin necessary to fuel
branched F-actin polymerization in protrusion as described by
Lomakin et al in single epithelial cells (Lomakin et al, 2015).
Together, our results show that ROCK activity synchronizes the
cytoskeleton to harness CRC invasive behaviour. ROCK inhibitors
being already used in the clinic for the treatment of several cardio-
vascular conditions, it has been proposed to target ROCK in cancer
patients to prevent or reduce invasion and metastasis formation
(Croft et al, 2004; Narumiya et al, 2009; Sadok & Marshall, 2014;
Vennin et al, 2017). Yet, it remains essential to account for cancer
heterogeneity and elucidate the tumour specific context enabling
pro or anti-invasive functions of this kinase in order to propose rele-
vant therapeutic strategies to patients and avoid paradoxical effects.
Materials and Methods
Primary specimens from colorectal carcinoma patients
The human study protocols followed all relevant ethical regulations
in accordance with the declaration of Helsinki principles. Tumour
specimens were obtained after informed patient consent at Gustave
Roussy Hospital.
Live cancer specimens
Primary tumour and metastasis explants were retrieved from CRC
patients at the time of surgery. The freshly isolated samples were trans-
ferred to sterile tubes. DMEM containing 4.5 g/l glucose, glutaMAX
(Life Technologies, 31966021) and 100 UI/ml penicillin, 100 lg/ml
streptomycin (1% P/S) (Life Technologies, 15140-122) was added to a
final volume of 10 ml. The freshly isolated tumours were minced into
small fragments and incubated under shaking conditions for 55 min to
1 h 15 at 37°C in a final volume of 1 to 5 ml of DMEM supplemented
with 2 mg/ml of collagenase. Digested tumour clusters were filtered
through a 100-lm filter and pelleted for 5 min at 850 g. The pellet was
resuspended in 10 ml of complete DMEM and pelleted for 10 s at
850 g, and finally, the resuspended pellet in 10 ml of complete DMEM
was pelleted by 3–5 pulse centrifugations from 850 g to 425 g. The
tumour fragments, free of single cells, were embedded in 100%
Matrigel in a culture dish, and DMEM supplemented with 10% FBS
was added on top. Culture was maintained 3 days for recovery. Then,
explants were washed in DMEM, pelleted at 500 g and used for inva-
sion assay.
Fixed cancer specimens
Primary CRC and metastases specimens obtained after surgical
resection were formalin-fixed and paraffin-embedded (FFPE)
according to hospital routine protocols. We selected NOS “Not
Otherwise Specified” types of CRC (also called lieberkuhnian or
adenocarcinoma in the World Health Organization classification). 3-
lm sections of FFPE samples were deparaffinised, unmasked (Ph8)
and rehydrated prior haematoxylin–eosin–saffron (HES) or Alcian
blue staining, immunohistochemistry or immunofluorescence. For
the specific view of the CRC invasion margin, the tumours were cut
with one transverse incision to expose a full view of the invasion
margin at its deepest point. From the invasion margins, several
cubes of about 1 × 1 × 1 mm were immersion fixed in buffered
glutaraldehyde (4%), blocked in epoxy resin and cut serially at
0.5 lm thickness. A Movat’s stain was used for light microscopic
study. For electron microscopy, the epoxy resin blocks were
trimmed for visualization of areas with invasive neoplastic glands.
50-nm ultrathin sections were taken, mounted on copper grids (200
mesh) and contrasted with uranyl acetate and lead citrate.
Organoids from Patient-derived Xenograft (PDX)
Animal experiments were compliant with French legislation and EU
Directive 2010/63. The project was validated by the Ethical Committee
(CEEA) no. 26 and was then granted French government authoriza-
tions under number 517-2015042114005883. Mice were obtained from
Charles River, housed and bred at the Gustave Roussy animal core
facility (accreditation number E-94-076-11). Animals were humanely
euthanized according to end points that were validated by the Ethical
Committee and the French government (Ministe`re de l’Enseignement
Supe´rieur, de la Recherche et de l’Innovation). The human colorectal
tumour corresponding to LRB-0010P from the CReMEC tumour collec-
tion was maintained in NOD SCID Gamma (NSG from Charles River,
France) mice as previously described by Julien et al (2012). Briefly,
small tumour fragments were subcutaneously engrafted on the flank of
anesthetized mice (2.5% isoflurane). Tumour growth was measured at
least once a week. When the volume reached 1,000–1,500 mm3, mice
were sacrificed and tumours were used for ex vivo experiments and 50-
mm3 fragments engrafted on the flank of new mice. Organoids were
prepared as described previously (Ewald et al, 2012). Tumours were
minced into small fragments and were incubated for 1 h 30 at 37°C in
a final volume of 5–10 ml of DMEM supplemented with 2 mg/ml of
collagenase. Digested tumour clusters were pelleted by 4 pulse
centrifugations at 1,500 rpm. The tumour fragments, free of single
cells, were maintained 3 days in culture medium supplemented with
15% Matrigel to allow formation of polarized organoids. Then,
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organoids were washed in DMEM, pelleted at 1500 rpm and used for
invasion assay.
Cell lines and culture conditions
Colorectal carcinoma cell line Caco-2 and T84 were purchased at
ATCC and grown in complete medium (DMEM/GlutaMAX for
Caco2 and DMEM/F12 for T84), supplemented with 10% foetal
bovine serum (FBS) and 1% P/S. Normal colon fibroblast cells,
CCD-18CO (ATCC), were grown in Eagle’s Minimum Essential
Medium supplemented with 1% non-essential amino acids (NEAA)
10% FBS and 1% P/S and used at 70–80% confluence to produced
conditioned media (harvested after 24 h and stored at 20°C until
use). All cells were grown in a humidified atmosphere at a temper-
ature of 37°C and with 5% CO2.
Caco-2 and T84 cyst morphogenesis
The following mix was used to coat the wells of 8-well Ibidi cham-
ber (10 ll per well): Matrigel was mixed with Rat-tail Collagen-I
neutralized with NaOH (1M), Hepes (1M) and MEM (10x) (Life
Technologies, 21430-02) according to the ratio
0.843:0.025:0.032:0.1 (vol/vol/vol/vol), adjusted with DMEM 1X
and allowed to polymerize in ice for 30 min before adding the
Matrigel and coating the dish. Polymerization occurred within
30 min at room temperature. The final concentrations of the mix
were 4.5 mg/ml for Matrigel and 1.3 mg/ml for Collagen-I. Caco-2
cells were dissociated into single cells with trypsin–EDTA and
resuspended in ice-cold DMEM complete medium supplemented
with Matrigel (2%), and cholera toxin (0.01 lg/ml) (DMEM-MG-
CT). The cell suspension was then added on top of the coating
(105 cells per well). The morphogenesis proceeded for 3 days at
37°C to allow formation of Caco-2 cysts.
Invasion assays
Patient primary cancer specimens and organoids
Tumour explants and organoids were embedded in 2 mg/ml
neutralized rat collagen-I and added on top of the pre-coated well
at a concentration of 1–2 cluster per microlitre. The gel was
allowed to polymerize for 45 min at 37°C. Culture medium
supplemented with FBS (10%) was added to the wells, and inva-
sion was allowed to proceed for up to 6 days. In fixed experi-
ments, invasive explants and organoids were defined as the ones
with strand of cells invading the 3D matrix led by protrusive cells
at the front. At least 40 organoids and 50 explants were counted
per condition.
Caco-2 and T84 cyst invasion assays
1/After morphogenesis, the complete medium supplemented with
2% Matrigel (+/ lentiviruses) was discarded, while the cysts
remained adherent to the Matrigel/Collagen-I coating. Collagen-I at a
final concentration of 1.3 mg/ml was added on top of the Caco-2
cysts and allowed to polymerize 15 min at room temperature. Then,
CCD-18-CO cells conditioned medium supplemented with cholera
toxin with or without inhibitors was added on top of the cysts. Caco-
2 cysts were allowed to perform invasion for 2 days at 37°C. 2/The
adapted Boyden chamber invasion assay: Caco-2 cyst morphogenesis
was allowed to proceed on the top chamber of the Boyden as
follows: Matrigel mixed with ice-cold DMEM 1X to a final concentra-
tion of 4.5 mg/ml was used to coat the top side of the Boyden
membrane (4 ll per membrane) and allowed to polymerize at 37°C
for 10 min. Caco-2 cells were dissociated into single cells and resus-
pended in ice-cold DMEM with 2% Matrigel and cholera toxin. The
cell suspension was then added on the top chamber and left to form
cysts for 3 days at 37°C. Once the cysts were formed, a growth factor
gradient was created by replacing the top’s chamber complete
medium with 2% Matrigel without FBS, whereas the bottom cham-
ber was renewed with DMEM supplemented with FBS (10%). Caco-2
cells were allowed to invade towards the bottom chamber for
2 days.
The number of invaded cells was calculated using an automated
segmentation analysis after nucleus staining (Hoechst) using the
Metamorph “count nuclei” application.
Small molecules inhibitors
H1152 (Tocris, 2414), Y27632 (Calbiochem, 688000), blebbistatin
(Calbiochem, 203391), NSC-23766 (Tocris, 2161) were used at
2 lM, 25 lM, 10 to 25 lM and 200 lM, respectively, doxycycline
(Sigma-Aldrich, D9891) was used at 1 lg/ml.
SiRNA transfection
siRNA oligonucleotides on-target smart pools targeting Rho-GTPases
effectors and GEFs were purchased from DharmaconTM. The
complete list of genes and corresponding catalogue numbers is
provided in Tables EV1 and EV2. siRNA (100 nM) were transfected
into Caco-2 cells using Dharmafect 1 Transfection Reagent (Dharma-
conTM, T-2001, 1:57) diluted in Opti-MEM medium (Gibco,
31985070). Briefly, Caco-2 cells were plated in culture dish in
complete medium, the day after the medium was replaced with
complete medium without antibiotics and the siRNA/Dharmafect
mix (1:5) was added to the medium. After 6 h, the transfection
medium was replaced with complete medium. The cells were
allowed to recover overnight before embedding into 3D matrices (the
effector screen was performed in Caco-2 cysts cultivated in 3D
Matrigel and collagen-I. The GEFs screen was carried out in the 3D
Boyden Chamber assay).
shRNAs reagents
ROCK shRNAs were provided in a pLKO.1 expression vector and
were purchased from Sigma; shRNA ROCK1 (TRCN0000195202)
shRNA ROCK2 (TRCN0000194836). shRNAs targeting FARP1 and
FARP2 were purchased from Thermofisher and provided in a pGIPZ
expression vector; FARP1#1 (V3LHS_325427), FARP1
#2 (V3LHS_325430), FARP2#1 (V2LHS_95483), FARP2#2 (V3LHS_
369923), FARP2#3 (V2LHS_369924), FARP2#4 (V2LHS_369925). All
vectors encoding shRNAs were transduced using lentiviruses (see
below).
Expression vector
The Tet-inducible dominant active Rock2 lentivirus construct (Rock2-
DA) was provided by Sanjay Kumar (Addgene pSlik-Rock2: 84649).
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Expression vectors (Gateway cloning system)
cDNAs of FARP1-FL, FARP2-FL, FARP2-Mut, FARP2-del and FARP2-
del/Mut, provided by Pr. Zhang (He et al, 2013), were cloned into
lentiviral expression vectors pLV-Nter cherry and ROCK2DN#1;
ROCK2DN#2 cDNAs were cloned into lentiviral expression vectors
pLV-Nter-GFP using the Gateway recombination cloning system. To
generate the entry clones (pDONR221), all cDNAs were obtained by
polymerase chain reaction (PCR) using the Phusion High-fidelity
Taq DNA polymerase (NEB, M0530) according to the manufacturer
instructions. pDONR221-ROCK2DN#2 was generated using oligonu-
cleotide-directed PCR mutagenesis to create an Asn to Thr and a Lys
to Thr replacement at amino acids 1036 and 1037, respectively,
from pDONR221-ROCK2DN#1. The following primers were used:
Lentiviruses transduction
Virus production
The shFARP1#1 and #2, shFARP2#1 and #2, shROCK1#02,
shROCK2#36, ROCK2DN#1, ROCK2DN#2, FARP1, FARP2-FL,
FARP2Mut, FARP2delMut lentiviral particles were obtained by trans-
fecting the respective expression lentiviral vectors with the packag-
ing vectors pMD2G (Addgene, 12259) and pCMVdR8.74 (Addgene,
22036) into HEK293T (ATCC) cells with the transfection reagent
JetPrime (Polyplus, 114-15, 1:250) diluted in the JetPrime buffer
(Polyplus, 712.60). Lentiviruses-containing supernatants were
collected on days 2 and 3 following transfection and were concen-
trated by ultracentrifugation (24,500 g, 2 h) and then stored at
80°C.
Construct name Primer name Primer sequence Template
pDONR-FARP1-FL F1STARTMET-For 50 GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTC ATG GGA GAA ATA GAG CAG AGG 30 pCDNA3.1+FARP1-
FL nter flag (human)
F1ENDSTOP-Rev 50 GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC TCA ATA CAC AAG AGA CTC TTT GTG 30
pDONR-FARP2-FL F2STARTMET-For 50 GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTC ATG GGA GAG ATA GAA GGA ACA TAC 30 pCDNA3.1+FARP2-
FL nter flag (mouse)
F2ENDSTOP-Rev 50 GGGG AC CAC TTT GTA CAA GAA AGC TGG GTC TCA GAG GTT CTT GTC CAA GCAGGGT 30
pDONR-FARP2-Mut F2STARTMET-For 50 GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTC ATG GGA GAG ATA GAA GGA ACA TAC 30 pCDNA3.1+FARP2-
Mut nter flag
(mouse)
F2ENDSTOP-Rev 50 GGGG AC CAC TTT GTA CAA GAA AGC TGG GTC TCA GAG GTT CTT GTC CAA GCAGGGT 30
pDONR-FARP2-Del F2STARTMET-For 50 GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTC ATG GGA GAG ATA GAA GGA ACA TAC 30 pCDNA3.1+FARP2-
del nter flag (mouse)
F2ENDSTOP-Rev 50 GGGG AC CAC TTT GTA CAA GAA AGC TGG GTC TCA GAG GTT CTT GTC CAA GCAGGGT 30
pDONR-FARP2-
del/Mut
F2STARTMET-For 50 GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTC ATG GGA GAG ATA GAA GGA ACA TAC 30 pCDNA3.1+FARP2-
del/Mut nter flag
(mouse)
F2ENDSTOP-Rev 50 GGGG AC CAC TTT GTA CAA GAA AGC TGG GTC TCA GAG GTT CTT GTC CAA GCAGGGT 30
pDONR-Rock2-
DN#1
R2-1STARTMET-For 50 GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTC ACC ATG
GAA AAA GAG AAG ATC ATG AAA GAG 30
pCDNA3-ROCK2-
FL (human)
(Sebbagh et al,
2005)
R2-1ENDSTOP-Rev 50 GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC TTA GCT AGG TTT GTT TGG GGC AAG 30
Rock2-DN#1 mutagenesis (Asn-Lys to Thr-Thr)
Construct name Primer sequence Template
pDONR-Rock2-
DN#2
50 CTC AAA ACT CAA GCT GTG ACT ACG TTG GCT GAG ATC ATG AAT CG 30 pDONR-Rock2-DN#1
Construct name Primer name Primer sequence Template
pDONR-FARP1-FL F1STARTMET-For 50 GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTC ATG GGA GAA ATA GAG CAG AGG 30 pCDNA3.1+FARP1-
FL nter flag (human)
F1ENDSTOP-Rev 50 GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC TCA ATA CAC AAG AGA CTC TTT GTG 30
pDONR-FARP2-FL F2STARTMET-For 50 GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTC ATG GGA GAG ATA GAA GGA ACA TAC 30 pCDNA3.1+FARP2-
FL nter flag (mouse)
F2ENDSTOP-Rev 50 GGGG AC CAC TTT GTA CAA GAA AGC TGG GTC TCA GAG GTT CTT GTC CAA GCAGGGT 30
pDONR-FARP2-Mut F2STARTMET-For 50 GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTC ATG GGA GAG ATA GAA GGA ACA TAC 30 pCDNA3.1+FARP2-
Mut nter flag
(mouse)
F2ENDSTOP-Rev 50 GGGG AC CAC TTT GTA CAA GAA AGC TGG GTC TCA GAG GTT CTT GTC CAA GCAGGGT 30
pDONR-FARP2-Del F2STARTMET-For 50 GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTC ATG GGA GAG ATA GAA GGA ACA TAC 30 pCDNA3.1+FARP2-
del nter flag (mouse)
F2ENDSTOP-Rev 50 GGGG AC CAC TTT GTA CAA GAA AGC TGG GTC TCA GAG GTT CTT GTC CAA GCAGGGT 30
pDONR-FARP2-
del/Mut
F2STARTMET-For 50 GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTC ATG GGA GAG ATA GAA GGA ACA TAC 30 pCDNA3.1+FARP2-
del/Mut nter flag
(mouse)
F2ENDSTOP-Rev 50 GGGG AC CAC TTT GTA CAA GAA AGC TGG GTC TCA GAG GTT CTT GTC CAA GCAGGGT 30
pDONR-Rock2-
DN#1
R2-1STARTMET-For 50 GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTC ACC ATG
GAA AAA GAG AAG ATC ATG AAA GAG 30
pCDNA3-ROCK2-FL
(human) (Sebbagh
et al, 2005)
R2-1ENDSTOP-Rev 50 GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC TTA GCT AGG TTT GTT TGG GGC AAG 30
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Lentiviral Infection of Caco-2 single cells and cysts
Caco-2 was infected at a MOI = 1. Lentiviral particles were added
to Caco-2 cells in suspension (2.105 cells/ml) in complete
medium supplemented with protamine (8 lg/ml) and were left to
adhere and grow for 3 days. pGIPZ and pLKO-transduced Caco-2
cells were trypsinized and selected in puromycin (6 lg/ml)-
supplemented complete medium. Cysts were transduced with
1.104 to 1.105 per ml of lentiviral particles to reach a mosaic or
acute transduction of the cyst. Briefly, after 3 days of Caco-2 cyst
morphogenesis in Ibidi chambers, the 2% Matrigel (BD, 354230)
supernatant medium was removed and replaced with complete
medium supplemented with Cholera Toxin (0.05 lg/ml) mixed
with the appropriate amount of lentiviral particles. The Ibidi was
kept 24 h at 37°C before fixation or performing the invasion
assay.
Immunofluorescence (IF) and antibodies
Samples were washed twice in PBS supplemented with calcium
(0.1 mM) and magnesium (1 mM) (PBS-CM) and fixed in PFA (4%)
diluted in PBS-CM for 10 min for coverslips and tissue sections,
30 min for Caco-2 cysts and 45 min for organoids. Permeabilization
was performed in PBS supplemented with 0.1% Triton X-100 during
10 min for coverslips and tissue sections, 0.5% Triton X-100 during
30 min for Caco-2 cysts and organoids. Samples were washed and
incubated with primary antibodies diluted in PBS with 10% FBS
(supplemented with 0.1% Triton X-100 for organoids) 1 h at room
temperature for coverslips, overnight at 4°C for Caco-2 cysts, tissue
section and organoids. Then, samples were washed in PBS-T (PBS–
Tween-20 0.05% for Caco-2 cysts and organoids) and incubated
with secondary antibodies diluted in antibody diluent at least
45 min at room temperature. After washing, the coverslips and
tissue sections were mounted using Fluoromount-G (Southern
Biotech, 0100-01).
The following primary antibodies were used at the indicated
dilutions: ROCK1 (1:1,000, Abcam, ab134181), ROCK2 (1:1,000,
Santa Cruz, sc-5561), E-cadherin (1:100, Abcam, ab1416), E-
cadherin (1:100, Cell Signaling Technology, 3195S), phospho-
ERM (1:100, Cell Signaling Technology, 3149), ezrin (1:100, BD
Biosciences, 610603), ZO-1 (1:200, Invitrogen, 40-2300), beta-
catenin (1:100, Thermofisher, MA1-300), vimentin (1:100, Ther-
mofisher, PA1-16759), alpha-catenin (1:100, Sigma-Aldrich,
C2081), Alexa FluorTM Phalloidin 488 (1:200, Thermofisher,
A12379).
Primary CRC sections staining and antibodies
Colorectal cancer specimens were immunostained with mouse
monoclonal antibodies against E-cadherin (4A2C7, Invitrogen),
vimentin (Thermofisher, PA1-16759), EpCam (1:100, Thermofisher,
MA5-12436) and villin (1:100, Cell Signalling Technology, R814).
For immunohistochemistry, stainings were performed with Ventana
BenchMark XT immunostainer (Ventana Medical Systems, Tucson,
AZ) utilizing UltraView DABv3 kit (Ventana, 7600-500). The chro-
mogene was 3,30-diaminobenzidine (DAB) in all the stainings. For
immunofluorescence, stainings were performed as described for
organoids.
Microscopy acquisition, live imaging and software-based
quantification
Images were acquired using an Olympus Epifluorescence inverted
X73 microscope, a confocal SpinningDisk CSU-W1 (Yokogawa) with
a ZylasCMOC camera piloted with an Olympus X83 or a transmis-
sion electron microscope Libra 120 (Carl Zeiss).
Patients’ specimens and Caco-2 cyst
Patients’ specimens and Caco-2 cyst behaviours in 3D culture were
imaged for up to 6 days by DIC time-lapse microscopy with motor-
ized stage, temperature and CO2 controllers.
Quantitative IF images analysis
The invasion rate of the Caco-2 cysts invading into the adapted
3D Boyden chamber invasion assay was automatically quantified
using the automated segmentation function of metamorph
software.
Linescan analysis
Following Caco-2 cells transfection with pEGFP-FARP2, Metamorph
software was used to trace lines crossing the cell–cell contact of
fixed Caco-2 cells plated on 2D coverslips overexpressing GFP-
FARP2 and stained for ZO-1 junctional protein. The quantification
has been performed on 71 cells expressing GFP-FARP2-FL from 3
independent experiments. For each cell, between 10 and 15 regions
(12 pixels wide) were drawn across the plasma membrane based on
the endogenous ZO-1 staining using Metamorph. The fluorescence
intensities were extracted for both channels (red (ZO-1) and the
green (GFP-FARP2)). Importantly, the images were acquired at a
constant exposure time for each staining (ZO-1 and GFP-FARP2).
Average fluorescence intensity was calculated from at least 10 lines
of 20 lm around each cell. The ratio of GFP-FARP2:ZO-1 maximum
intensities was calculated.
Image display
Images were scaled relative to minimum and maximum pixel
intensity of the image (non-linear adjustment (Gamma) was not
used).
Rac-GTP Pull-down from tridimensional cultures
Caco-2 cysts were formed on 22-cm2 culture dishes: briefly, 22-
cm2 dishes were coated with the Matrigel/Collagen-I (Corning,
354236) mix (110 ll/dish) prepared as described in the “Caco-2
cyst morphogenesis” section (described below) and Caco-2 cells
(1.106 cell/ml) resuspended in complete medium supplemented
with 2% Matrigel and cholera toxin (0.01 lg/ml) were added on
top of the coating. After 3 days, Caco-2 cysts were treated with
Y27632 (12 h, 25 lM) or with H1152 (16 h, 2 lM). Caco-2 cysts
were then incubated 15 min with 2 mg/ml of collagenase (Sigma-
Aldrich, C2139) in DMEM. The collagenase digestion was termi-
nated by addition of complete medium and the cysts washed
twice with ice-cold PBS supplemented with MgCl2 (25 mM). Caco-
2 cysts were scraped from dish in ice-cold PBS-MgCl2, transferred
to tubes and separated from the matrix by pelleting through 3
successive centrifugations of 1 min at 1,500 rpm. Retrieved Caco-2
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cysts were then lysed in lysis buffer (50 mM Tris–HCl pH 7.5, 1%
Triton X-100, 25 mM MgCl2, 500 mM NaCl, 40 mM Na pyrophos-
phate, 1 mM NaVO4, 2 mM phenylmethylsulphonyl fluoride
(PMSF), 0.025% deoxycholate, 10 lg/ml aprotinin, 10 lg/ml
leupeptin). Lysates were clarified by centrifugation, and equal
amounts of protein lysates were incubated with 20 ll of purified
glutathione S-transferase (GST)-CRIB immobilized on glutathione–
Sepharose beads (17-0756-01, GE Healthcare) for 1 h rocking at
4°C. The beads were washed and incubated with SDS sample
buffer (62.5 mM Tris–HCl pH 6.8, 10% glycerol, 0.002%
bromophenol blue, 2% SDS and 5% b-mercaptoethanol) and
boiled for 10 min. The samples were analysed for Rac1 pull-down
by Western blot using an anti-Rac1 antibody (1:500; Cell Signal-
ing, Beverly, MA).
Co-Immunoprecipitation
Caco-2 cells were transfected with plasmids expressing GFP-
ROCK2DN#1 or GFP-ROCK2DN#2, lysed after 48 h with lysis
buffer. Protein lysates were clarified by centrifugation, and equal
amounts of protein lysates were incubated with GFP-trapbeads
(gta-10; ChromoTek). The beads were then washed with lysis
buffer and incubated 10 min at 95°C in SDS sample buffer before
Western blot analysis with anti-ROCK1, anti-ROCK2 and anti-eGFP
antibodies.
Western Blot and antibodies
Appropriately treated cells were lysed in lysis buffer and equal
amount of proteins were boiled for 10 min in SDS sample buffer.
The samples were subjected to SDS–polyacrylamide gel elec-
trophoresis (PAGE) using precast acrylamide gels (Thermofisher,
NP0335BOX), and proteins were transferred to nitrocellulose
membranes. Membranes were incubated for 30 min in Blocking
solution (Tris-buffered saline (TBS) containing 0.1% Tween-20, 3%
BSA or 5% milk) and further incubated with the appropriate
primary antibody diluted in Blocking solution at 4°C overnight. The
membranes were then washed three times with TBS–Tween (0.1%)
and incubated for 45 min with secondary antibody conjugated to
horseradish peroxidase (HRP). Bound antibodies were detected with
enhanced chemiluminescence.
The following primary antibodies were used at the indicated dilu-
tions: HSC70 (1:4000, Santa Cruz, sc-7298), GAPDH-HRP (1:10,000,
Abcam, ab9482), ROCK1 (1:1,000, Abcam, ab134181), ROCK2
(1:1,000, Santa Cruz, sc-5561), FARP1 (1:100, Santa Cruz, sc-
293249), FARP2 (1:50, Santa Cruz sc-390744), GFP (1:1,000 Santa
Cruz, sc-8334), eGFP (1:1,000, Covance), RAC1 (1:500, BD
Bioscience, 610650).
ROCK2 expression data
ROCK2 mRNA expression was evaluated in the large Affymetrix
U133Plus gene expression data set GSE33582 from (Marisa et al
2013) which includes profiles from 566 colon tumours and 19 non-
tumour tissues (NT). The values of the two probeset corresponding
to ROCK2 gene were average, and the value was discretized rela-
tively to the expression of ROCK2 in non-tumour tissues (tumours
with values inferior to the 1st decile (7.6) of the expression in NT
were defined as tumours with a down-regulation of ROCK2). Overall
survival curves were obtained using Kaplan–Meier estimates and
differences between survival distributions were assessed by a log-
rank test with an end point at 3 and 5 years.
Statistical analyses
The normal distribution of the protrusive phenotype in patient
explants and cell lines in control condition was verified using the
Shapiro–Wilk normality test. Parametric, paired and unpaired two-
tailed t-tests were performed to determine whether the difference
between control and treated groups was significantly different in their
mean value using Prism 6. All errors indicated in the text are SEM.
Expanded View for this article is available online.
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